Alterity Therapeutics (ATHE) Non-Current Assets (2015 - 2025)
Alterity Therapeutics' quarterly Non-Current Assets came in at $62953.8 in Q4 2025, down 16.83% year-on-year from $75696.1 in Q4 2024, and down 36.65% quarter-over-quarter from $99378.6 in Q2 2025.
Alterity Therapeutics has reported Non-Current Assets for 11 years, with the latest figure at $62953.8 in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Assets fell 16.83% year-over-year to $62953.8; the trailing twelve-month figure through Dec 2025 stood at $62953.8 (down 16.83% YoY), and the FY2025 full-year result was $99378.6, down 19.31% from the prior year.
- Non-Current Assets for Q4 2025 stood at $62953.8, down from $99378.6 in the prior quarter.
- The five-year high for Non-Current Assets was $147018.0 in Q2 2024, with the low at $2688.6 in Q2 2023.
- Average Non-Current Assets over 5 years is $85487.0, with a median of $86958.3 recorded in 2024.
- Year-over-year, Non-Current Assets sank 97.26% in 2023 and soared 5368.14% in 2024.
- Tracing ATHE's Non-Current Assets over 5 years: stood at $49763.2 in 2021, then soared by 130.58% to $114742.3 in 2022, then rose by 13.18% to $129861.5 in 2023, then sank by 41.71% to $75696.1 in 2024, then dropped by 16.83% to $62953.8 in 2025.
- The last three Non-Current Assets figures came in at $62953.8 (Q4 2025), $99378.6 (Q2 2025), and $75696.1 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 285.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62,953.78 |
| Jun 30, 2025 | 99,378.58 |
| Dec 31, 2024 | 75,696.13 |
| Jun 30, 2024 | 147,018.00 |
| Dec 31, 2023 | 129,861.53 |
| Jun 30, 2023 | 2,688.63 |
| Dec 31, 2022 | 114,742.29 |
| Jun 30, 2022 | 98,220.44 |
| Dec 31, 2021 | 49,763.16 |
| Jun 30, 2021 | 74,547.50 |
| Dec 31, 2020 | 27,943.64 |
| Jun 30, 2020 | 46,776.71 |
| Dec 31, 2019 | 80,161.29 |
| Jun 30, 2019 | 34,146.62 |
| Dec 31, 2018 | 43.04 |
| Jun 30, 2018 | 54,069.09 |
| Dec 31, 2017 | 19,384.39 |
| Jun 30, 2017 | 23.14 |
| Dec 31, 2016 | 59,903.90 |
| Jun 30, 2016 | 50.93 |
| Dec 31, 2015 | 56,618.02 |
| Jun 30, 2015 | 70.12 |